Background: Most infants with congenital Cytomegalovirus (CMV) infection are born to seropositive women as a result of maternal CMV nonprimary infection (reinfection or reactivation). Although infected children are known to transmit CMV to their seronegative mothers, the frequency and magnitude of nonprimary maternal CMV infection after exposure to viral shedding by children in their household have not been characterized. Methods: A cohort of Ugandan newborns and their mothers were tested weekly for CMV by quantitative polymerase chain reaction of oral swabs. Infant primary infection and maternal nonprimary infection were defined by the onset of persistent high-level oral CMV shedding. Strain-specific antibody testing was used to assess maternal reinfection. Cox regression models with time-dependent covariates were used to evaluate risk factors for nonprimary maternal infection. Results: Nonprimary CMV infection occurred in 15 of 30 mothers, all after primary infection of their infants by a median of 6 weeks (range: 1-10) in contrast to none of the mothers of uninfected infants. The median duration of maternal oral shedding lasted 18 weeks (range: 4-42) reaching a median maximum viral load of 4.69 log copies/mL (range: 3.22-5.64). Previous-week infant CMV oral quantities strongly predicted maternal nonprimary infection (hazard ratio: 2.32 per log 10 DNA copies/swab increase; 95% confidence interval: 1.63-3.31). Maternal nonprimary infections were not associated with changes in strain-specific antibody responses. Conclusions: Nonprimary CMV infection was common in mothers after primary infection in their infants, consistent with infant-to-mother transmission. Because infants frequently acquire CMV from their mothers, for example, through breast milk, this suggests the possibility of "ping-pong" infections. Additional research is needed to characterize the antigenic and genotypic strains transmitted among children and their mothers.
C ytomegalovirus (CMV) is the most common congenital infection and an important cause of sensorineural hearing loss and intellectual disability in children worldwide. 1, 2 Maternal CMV infection acquired before conception offers incomplete protection against transmission to the fetus, and most cases of congenital CMV infection are associated with nonprimary maternal CMV infection during pregnancy. 3, 4 Nonprimary CMV infection has been defined by detection of active CMV infection in a previously infected individual after a period of at least 4 weeks without detectable virus during active surveillance, 5 and results from either reactivation of endogenous (latent) virus or reinfection by exogenous virus. [6] [7] [8] Reinfection is defined as detection of a CMV strain that is distinct from the strain that was the cause of the patient's original infection; reactivation is assumed if the 2 strains are the same. 5 Postnatal CMV primary infection in infants often occurs through breastfeeding, [9] [10] [11] but horizontal transmission through shedding in saliva and urine of other children is also common. After primary CMV infection, young children shed virus at high levels for prolonged periods in saliva and urine. 12, 13 Exposure to young children is therefore a risk factor for primary CMV infection in women of childbearing age. [14] [15] [16] In adults with chronic infection, transient viral shedding in saliva or urine has been described. [17] [18] [19] [20] CMV shedding in breast milk is detected in 40%-99% of lactating seropositive women and leads to postnatal transmission. [21] [22] [23] [24] [25] This study presents the analysis of oral CMV shedding patterns in a well-characterized prospective cohort of mothers and children in Uganda and describes the novel observation that nonprimary CMV infection in women commonly occurs shortly after postnatal primary infection of their infants.
MATERIALS AND METHODS

Study Cohort and Data Collection
A birth cohort of 32 mother-infant pairs was established in Uganda, as previously described. 11 Briefly, pregnant women attending prenatal care in Kampala were recruited between 2008 and 2010. Eligibility required having documented HIV-1 status, at least one other preschool-age ("secondary") child living in the home, and stable residence in the Kampala area. After delivery, oral swab samples were collected from the women, the newborns and their household contacts weekly. A standardized questionnaire was administered at each study visit, which included information about breastfeeding and other maternal behaviors that might expose principal children to saliva (premastication of food, sharing drinking cups or eating utensils, rubbing saliva into a bite or wound or kissing on the mouth) during the previous week. Blood samples were collected from the newborn at 6 weeks of age, and every 4 months thereafter. Blood samples were collected from the mother at delivery and 1 year later. School-age children and fathers were rarely at home when study visits took place, and therefore were not included. The study was approved by the relevant ethics review boards in Uganda, the United States and Canada.
Sample Processing and Viral Testing
Oral swabs and plasma samples were tested for CMV using real-time quantitative polymerase chain reaction (PCR) as described. 11 The limit of detection was 150 copies/mL for swabs and 50 copies/mL for plasma.
Definitions of Infant Primary Infection
Detection of viral DNA in the plasma or ≥2 consecutive oral swabs of sufficient quantity (≥3.5 log 10 copies/mL) defined primary infection. 11 This threshold allows for the exclusion of transient episodes of oral shedding that are not consistent with primary infection in infants. 26 The onset of primary infection was defined as the date of the earliest positive PCR test within a window period ≤28 days before the samples used to meet the definition of primary infection. Newborns who met the definition of primary infection at the time of their first PCR sample (obtained at ≤2 weeks of life) were considered to have been infected in utero and excluded.
Definitions of Maternal Nonprimary Infection
We defined maternal nonprimary infection by detection of ≥3 log 10 copies/mL of CMV DNA in ≥2 consecutive weekly oral swabs. This lower viral threshold than the one used for primary infection in infants was chosen to allow for reduced viral loads in nonprimary compared with primary infection and in adults compared with infants. 27 The start of an episode was defined as the time of the first positive swab in this series that followed 2 consecutive negative swabs. The end of the recurrence was defined by the first 2 consecutive negative swabs.
CMV Serology
Diagnostic serology for CMV infection was performed using enzyme-linked immunosorbent assay kits [Wampole (Alere), Boucherville, Quebec, Canada]. CMV strain-specific antibody responses were determined using polymorphisms in antibody-binding sites within envelope glycoproteins gH and gB, between the 2 prototypical laboratory strains of CMV, AD169 and Towne. The detection of new antibody specificities to either epitope (AD169 or Towne) on gH or gB when comparing delivery to year 1 follow-up serum samples was considered evidence of acquisition of a new viral strain (reinfection).
6,7
Statistical Analyses
We assessed the following risk factors for maternal nonprimary infection: primary infant CMV infection, maternal HIV status and whether there was an oral contact between mother and infant. We defined oral contact using questionnaire data regarding whether a mother reported sharing saliva or food in the previous week. 11 We also analyzed household exposure by including the CMV shedding from the infants and the secondary children in the household. For households with multiple secondary children, we used the maximum value recorded in a given week as the shedding value. All variables were assessed between infant birth until either maternal nonprimary infection or the end of follow-up, whichever came first.
We analyzed the variables simultaneously using a Cox proportional hazard models with time-dependent covariates to account for the time to event data and censoring in the cohort. 28, 29 Maternal HIV was included as a time-independent variable, while oral contacts, infant oral viral load and secondary child oral viral load from the previous week were included as time-dependent covariates.
Infant infection status was defined in this cohort previously using their viral shedding data 11 and is correlated with persistent shedding, 30 so infant viral load was considered a continuous proxy for infant infection status. To handle missing data, we used the last observation carried forward. A sensitivity analysis using complete case analysis is presented in Table ( 
RESULTS
Study Cohort
After exclusion of 2 cases of congenital CMV infection, women from 30 households were followed for a median of 51 weeks (range: 3-52). All women had established CMV infection at delivery based on detection of CMV-specific immunoglobulin G in serum. Fifteen women were HIV infected, with a median CD4 at delivery of 441 cells/mm 3 (range: 385-885). There were 21 households with only 1 secondary child, 5 households with 2 and 4 households with 3. Of the 30 infants, 17 acquired CMV while the mothers were being followed. None of the infants were infected with HIV at birth or during follow-up.
Frequency and Timing of Maternal Nonprimary CMV Infection
Nonprimary CMV infection occurred in 15 mothers, all of whom had infants with primary CMV infection ( 
Risk Factors for Maternal Nonprimary CMV Infection
We first summarized risk factors from infant birth until maternal nonprimary infection or the end of maternal follow-up (Table 1) . Follow-up time was similar between mothers with and without nonprimary infection. The proportion of positive swabs and mean saliva shedding in infants was higher in households where maternal nonprimary infection was observed, a trend that was not pronounced in the secondary children (Table 1 and Fig. 1A-B,) . Reported oral contact behavior with infants and maternal HIV status was similar between households with and without maternal nonprimary infection.
Next, we considered the timing of risk factors and the relationship between weekly exposures and risk of maternal nonprimary infection in the subsequent week. The probability of maternal nonprimary infection was positively correlated with the quantity of oral shedding by infants in the previous week (Fig. 1C) , a Table 2 ). Number of maternal nonprimary infections/positive swabs shown below each bar. IQR indicates interquartile range.
pattern that was distinct from shedding by secondary children (Fig.  1D,) . We analyzed all risk factors in an adjusted Cox model with time-dependent variables for household shedding and reported oral contacts with infants (Table 2 ). Maternal nonprimary infection was statistically significantly associated only with increasing infant shedding levels during the previous week (hazard ratio: 2.32; 95% confidence interval: 1.63-3.31; P < 0.0001), consistent with the observed dose-response relationship (Fig. 1C,) . Maternal HIV status was not significantly associated with the risk of nonprimary CMV infection.
Serologic Evidence of Maternal CMV Reinfection
Among the 21 mothers who had serum samples collected at the end of the follow-up period, 8 had evidence of CMV reinfection as defined by a change in type-specific serologic responses compared with the time of delivery. Serologic evidence of CMV reinfection was not significantly associated with maternal nonprimary CMV infection: 2 of 9 women with nonprimary infection had serologic evidence of reinfection compared with 6 of 12 of women who did not have a nonprimary infection (Fisher exact test P = 0.37).
DISCUSSION
In our cohort of mother-infant pairs followed from the time of delivery, 50% of women were found to have a nonprimary CMV infection. Maternal nonprimary infection only occurred after infant primary CMV infection; no maternal nonprimary infections were observed to occur before infant infection or among women whose infants did not acquire CMV. This temporal relationship is evident both in the graphical data and in the multivariate regression results and suggests transmission from newly infected infants to their seropositive mothers. Our findings complicate the traditional paradigm of postnatal CMV transmission from mother to infant, by documenting maternal nonprimary CMV infection that follows (rather than precedes) primary infection in the infant. However, this is similar to the observations in seronegative women acquiring primary CMV infections from their young children.
We acknowledge that other routes of maternal nonprimary infection are possible. Mothers might have become reinfected with a different viral strain by a contact other than their own infant, though the consistent temporal association with infant infection undermines this explanation. Moreover, we failed to identify a relationship between oral CMV shedding by siblings and maternal nonprimary infection. Another potential explanation of our findings is that the nonprimary infections that we observed reflect reactivation rather than reinfection, although we think that it is unlikely that maternal reactivation should consistently occur after infant primary infection and in a statistically significant dose-dependent manner with infant CMV shedding. 31 Numerous studies have described that postnatal transmission of CMV occurs frequently from mothers to infants, which is often attributable to viral replication in breast milk that begins soon after delivery. [21] [22] [23] [24] [25] [32] [33] [34] Indeed, in this infant cohort, we reported that primary CMV infection was most strongly associated with breastfeeding. 11 Onset of CMV shedding in breast milk in previous studies was mainly within the first 2 weeks after delivery, [32] [33] [34] while the onset of maternal nonprimary infection in our study was 15 weeks after delivery. CMV shedding in breast milk preceding saliva could allow for the transmission of CMV to newborns before maternal nonprimary infection. However, such a defined temporal order of shedding by compartment seems unlikely given that previous studies have shown no correlation between CMV shedding between breast milk and saliva, 32, 33 and no maternal nonprimary infections were observed before or in the absence of infant infection.
Transmission from an infant to its seropositive mother might be expected to occur when the infant was infected by a contact other than its mother, with a different antigenic strain. However, many infants are infected by their mothers; indeed, in this cohort and others, breast milk was a major route of CMV transmission to infants. [9] [10] [11] Furthermore, there was no evidence of reinfection with different antigenic strains in this cohort of mothers, based on strain-specific serology. Therefore, we speculate that, at least in some cases, mothers transmitted CMV to their infants, who then reinfected these mothers. This "ping-pong" effect might occur with back and forth transmission of the same viral strain(s), or might be facilitated by step-wise antigenic changes that occur as a result of extensive genetic diversity of CMV within each host and between anatomic compartments (ie, breast milk and saliva or urine). [35] [36] [37] These changes likely would not be identified by CMV strainspecific antibody assay differences. Whatever the mechanism, the resulting dynamic of such highly permissive reinfection would have important implications for efforts to develop a vaccine to prevent CMV acquisition.
Strengths of our study include a prospective weekly sampling of mothers and children to allow detailed temporal and quantitative associations regarding CMV transmission and acquisition. While the clear temporal dose-response associations between infant and maternal oral shedding provide strong evidence for transmission from the infant to its mother, we were unable to definitively show that any given mother was the source of transmission to her infant, or that the mother's nonprimary infections were definitively attributable to exposure to their infant's CMV. Because the CMV strain-specific antibody assay only measures antibodies against 2 epitopes (one on gH and the other on gB), it is estimated to detect only a small number of strain differences among the enormous variability of human CMV strain. 38 Therefore, the absence of demonstration of strain difference by this assay is not evidence for reactivation. Comprehensive CMV genotyping of saliva and breast milk samples was not possible because of lack of adequate sample quantity or availability, but might help to determine the mechanism(s) by which maternal recurrence or oral shedding follows primary infection in infants if strains transmitted between infants and their mothers were genetically distinct. Other limitations include the lack of data about CMV shedding in breast milk and other potential CMV exposures, like fathers and school-age children. Last, these results may not be generalizable to other populations, for example, those with lower seroprevalence of CMV and other infections. As such, additional studies in other settings are needed.
In conclusion, this study describes clear temporal and doseresponse associations between oral CMV shedding by infants 
